1. Uchiyama, A.; Motegi, S.; Sekiguchi, A.; Fujiwara, C.; Perera, B.; Ogino, S.; Yokoyama, Y.; Ishikawa, O. Mesenchymal stem cells-derived MFG-E8 accelerates diabetic cutaneous wound healing. J. Dermatol. Sci. 2017, 86, 187–197. [CrossRef]
2. Mouiseddine, M.; Mathieu, N.; Stefani, J.; Demarquay, C.; Bertho, J.M. Characterization and histological localization of multipotent mesenchymal stromal cells in the human postnatal thymus. Stem Cells Dev. 2008, 17, 1165–1174. [CrossRef]
3. Payne, N.L.; Sun, G.; Mcdonald, C.; Layton, D.; Moussa, L.; Emerson-Webber, A.; Veron, N.; Siatskas, C.; Herszfeld, D.; Price, J.; et al. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Cell Transplant. 2013, 22, 1409–1425. [CrossRef]
4. Oh, S.Y.; Lee, S.J.; Jung, Y.; Lee, H.J.; Han, H.J. Arachidonic acid promotes skin wound healing through induction of human MSC migration by MT3-MMP-mediated fibronectin degradation. Cell Death Dis. 2015, 6, e1750. [CrossRef]
5. Huang, S.; Xu, L.; Zhang, Y.; Sun, Y.; Li, G. Systemic and Local Administration of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells Promotes Fracture Healing in Rats. Cell Transplant. 2015, 24, 2643–2655. [CrossRef]
6. Gupta, N.; Su, X.; Popov, B.; Lee, J.W.; Serikov, V.; Matthay, M.A. Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice. J. Immunol. 2007, 179, 1855–1863. [CrossRef]
7. Ge, J.; Guo, L.; Wang, S.; Zhang, Y.; Cai, T.; Zhao, R.C.H.; Wu, Y. The Size of Mesenchymal Stem Cells is a Significant Cause of Vascular Obstructions and Stroke. Stem Cell Rev. Rep. 2014, 10, 295–303. [CrossRef]
8. Karp, J.M.; Leng, T.G. Mesenchymal Stem Cell Homing: The Devil Is in the Details. Cell Stem Cell 2009, 4, 206–216. [CrossRef] [PubMed]
9. Zhang, L.; Li, K.; Liu, X.; Li, D.; Luo, C.; Fu, B.; Cui, S.; Zhu, F.; Zhao, R.C.; Chen, X. Repeated Systemic Administration of Human Adipose-Derived Stem Cells Attenuates Overt Diabetic Nephropathy in Rats. Stem Cells Dev. 2013, 22, 3074–3086. [CrossRef] [PubMed]
10. Bazhanov, N.; Ylostalo, J.H.; Bartosh, T.J.; Tiblow, A.; Mohammadipoor, A.; Foskett, A.; Prockop, D.J. Intraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs. Stem Cell Res. Ther. 2016, 7, 27. [CrossRef] [PubMed]
11. Ezquer, M.; Urzua, C.A.; Montecino, S.; Leal, K.; Conget, P.; Ezquer, F. Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice. Stem Cell Res. Ther. 2016, 7, 42. [CrossRef] [PubMed]
12. Himeoka, Y.; Kaneko, K. Enzyme oscillation can enhance the thermodynamic efficiency of cellular metabolism: Consequence of anti-phase coupling between reaction flux and affinity. Phys. Biol. 2016, 13, 026002. [CrossRef] [PubMed]
13. Aali, E.; Mirzamohammadi, S.; Ghaznavi, H.; Madjd, Z.; Larijani, B.; Rayegan, S.; Sharifi, A.M. A comparative study of mesenchymal stem cell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats. J. Diabetes Metab. Disord. 2014, 13, 76. [CrossRef] [PubMed]
14. Li, C.; Li, G.; Liu, M.; Zhou, T.; Zhou, H. Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function. J. Biosci. Bioeng. 2016, 121, 213–219. [CrossRef]
15. Burk, J.; Berner, D.; Brehm, W.; Hillmann, A.; Horstmeier, C.; Josten, C.; Paebst, F.; Rossi, G.; Schubert, S.; Ahrberg, A.B. Long-Term Cell Tracking following Local Injection of Mesenchymal Stromal Cells in the Equine Model of Induced Tendon Disease. Cell Transplant. 2016, 25, 2199–2211. [CrossRef]
16. Liu, Y.S.; Ou, M.E.; Liu, H.; Gu, M.; Lv, L.W.; Fan, C.; Chen, T.; Zhao, X.-H.; Jin, C.Y.; Zhang, X.; et al. The effect of simvastatin on chemotactic capability of SDF-1α and the promotion of bone regeneration. Biomaterials 2014, 35, 4489–4498. [CrossRef]
17. Matsuura, Y.; Atsuta, I.; Ayukawa, Y.; Yamaza, T.; Kondo, R.; Takahashi, A.; Ueda, N.; Oshiro, W.; Tsukiyama, Y.; Koyano, K. Therapeutic interactions between mesenchymal stem cells for healing medication-related osteonecrosis of the jaw. Stem Cell Res Ther. 2016, 7, 119. [CrossRef]
18. Rasband, W.S. ImageJ, U.S. National Institutes of Health: Bethesda, MD, USA, 1997–2018. Available online: https://imagej.nih.gov/ij/ (accessed on 28 November 2018).
19. Duscher, D.; Rennert, R.C.; Januszyk, M.; Anghel, E.; Maan, Z.N.; Whittam, A.J.; Perez, M.G.; Kosaraju, R.; Hu, M.S.; Walmsley, G.G.; et al. Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells. Sci. Rep. 2014, 4, 7144. [CrossRef]
20. Kurata, K.; Heino, T.J.; Higaki, H.; Väänänen, H.K. Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture. J. Bone Miner. Res. 2006, 21, 616–625. [CrossRef]
21. Atsuta, I.; Yamaza, T.; Yoshinari, M.; Goto, T.; Kido, M.A.; Kagiya, T.; Mino, S.; Shimono, M.; Tanaka, M. Ultrastructural localization of laminin-5 (γ2 chain) in the rat peri-implant oral mucosa around a titanium-dental implant by immuno-electron microscopy. Biomaterials 2005, 26, 6280–6287. [CrossRef]
22. Atsuta, I.; Yamaza, T.; Yoshinari, M.; Mino, S.; Goto, T.; Kido, M.A.; Terada, Y.; Tanaka, T. Changes in the distribution of laminin-5 during peri-implant epithelium formation after immediate titanium implantation in rats. Biomaterials 2005, 26, 1751–1760. [CrossRef] [PubMed]
23. Takamori, Y.; Atsuta, I.; Nakamura, H.; Sawase, T.; Koyan, K.; Hara, Y. Histopathological comparison of the onset of peri-implantitis and periodontitis in rats. Clin. Oral Implants Res. 2017, 28, 163–170. [CrossRef] [PubMed]
24. Von, D.F.; Kramer, M.; Wermke, M.; Wehner, R.; Röllig, C.; Alakel, N.; Stölzel, F.; Parmentier, S.; Sockel, K.; Krech, M.; et al. Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome. Stem Cells 2016, 34, 357–366.
25. Li, X.H.; Gao, C.J.; Da, W.M.; Cao, Y.B.; Wang, Z.H.; Xu, L.X.; Wu, Y.M.; Liu, B.; Liu, Z.Y.; Yan, B.; et al. Reduced Intensity Conditioning, Combined Transplantation of Haploidentical Hematopoietic Stem Cells and Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia. PLoS ONE 2014, 9, e89666. [CrossRef] [PubMed]
26. Antonio, U.; Lorenzo, M.; Vito, P. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008, 8, 726–736.
27. Kondo, R.; Atsuta, I.; Ayukawa, Y.; Yamaza, T.; Matsuura, Y.; Furuhashi, A.; Tsukiyama, Y.; Koyano, K. Therapeutic interaction of systemically-administered mesenchymal stem cells with peri-implant mucosa. PLoS ONE 2014, 9, e90681. [CrossRef]
28. Kanazawa, M.; Atsuta, I.; Ayukawa, Y.; Yamaza, T.; Kondo, R.; Matsuura, Y.; Koyano, K. The influence of systemically or locally administered mesenchymal stem cells on tissue repair in a rat oral implantation model. Int. J. Implant Dent. 2018, 4, 2. [CrossRef]
29. Holder, A.J.; Badiei, N.; Hawkins, K.; Wright, C.; Williams, P.R.; Curtis, D.J. Control of collagen gel mechanical properties through manipulation of gelation conditions near the sol-gel transition. Soft Matter 2018, 14, 574–580. [CrossRef]
30. Kimura, H.; Ouchi, T.; Shibata, S.; Amemiya, T. Stem cells purified from human induced pluripotent stem cell- derived neural crest-like cells promote peripheral nerve regeneration. Sci. Rep. 2018, 8, 10071. [CrossRef]
31. Ogawa, M.; Ogawa, S.; Bear, C.E.; Ahmadi, S.; Chin, S.; Li, B. Directed differentiation of cholangiocytes from human pluripotent stem cells. Nat. Biotechnol. 2015, 33, 853–861. [CrossRef]
32. Xie, L.; Zhang, N.; Marsano, A.; Vunjak, N.G.; Zhang, Y.; Lopez, M.J. In vitro mesenchymal trilineage differentiation and extracellular matrix production by adipose and bone marrow derived adult equine multipotent stromal cells on a collagen scaffold. Stem Cell Rev. Rep. 2013, 9, 858–872. [CrossRef] [PubMed]
33. Hou, C.; Shen, L.; Huang, Q.; Mi, J.; Wu, Y.; Yang, M.; Zeng, W.; Li, L.; Chen, W.; Zhu, C. The effect of heme oxygenase-1 complexed with collagen on MSC performance in the treatment of diabetic ischemic ulcer. Biomaterials 2013, 34, 112–120. [CrossRef] [PubMed]
34. Nakagawa, H.; Isaji, M.; Hayashi, M.; Tsurufuji, S. Selective inhibition of collagen breakdown by proteinase inhibitors in granulation tissue in rats. J. Biochem. 1981, 89, 1081–1090. [PubMed]
35. Kühl, T.; Mezger, M.; Hausser, I.; Handgretinger, R.; Bruckner, T.L.; Nyström, A. High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa. Mol. Ther. 2015, 23, 1368–1379. [CrossRef]
36. Lee, R.H.; Pulin, A.A.; Seo, M.J.; Kota, D.J.; Ylostalo, J.; Larson, B.L.; Semprun-Prieto, L.; Delafontaine, P.; Prockop, D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5, 54–63. [CrossRef]
37. Nagaishi, K.; Ataka, K.; Echizen, E.; Arimura, Y.; Fujimiya, M. Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells. Hepatology 2014, 59, 1816–1829. [CrossRef]
38. Zhang, Q.; Nguyen, P.; Xu, Q.; Park, W.; Lee, S.; Furuhashi, A. Neural Progenitor-Like Cells Induced from Human Gingiva-Derived Mesenchymal Stem Cells Regulate Myelination of Schwann Cells in Rat Sciatic Nerve Regeneration. Stem Cells Transl Med 2016, 5, 1–13. [CrossRef]
39. Peired, A.J.; Sisti, A.; Romagnani, P. Mesenchymal Stem Cell-based therapy for kidney disease: A Review of clinical evidence. Stem Cells Int. 2016, 4798639. [CrossRef]
40. Elizabeth, B.; Yanzhou, L.; Li, C.; Austin, M.G. Eicosanoids: Emerging contributors in stem cell-mediated wound Healing. Prostaglandins Other Lipid Mediat. 2016, 132, 17–24.
41. Yu, Y.; Wu, R.X.; Gao, L.N.; Xia, Y.; Tang, H.N.; Chen, F.M. Stromal cell-derived factor-1-directed bone marrow mesenchymal stem cell migration in response to inflammatory and/or hypoxic stimuli. Cell Adh. Migr. 2016, 10, 342–359. [CrossRef]
論文の公開元へ
